US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avid Bioservices, Inc.

12.49

0.0000

Volume:- -

Turnover:38.32M

Market Cap:798.90M

PE:-5.22

High:12.49

Open:12.49

Low:12.49

Close:12.49

52wk High:12.51

52wk Low:5.90

Shares:63.96M

Float Shares:50.62M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3946

EPS(LYR):-2.2271

ROE:-133.29%

ROA:-3.27%

PB:17.83

PE(LYR):-5.61

Loading ...

Overview Company News Filings

Bora Pharmaceuticals Unit to Buy CDMO Operational Assets for $18 Million

MT Newswires Live

Press Release: Piramal Pharma Limited Announces Results for Q3 and 9M FY26

NARMAFOTINIB Large-Scale Manufactre Complete

Press Release: Samsung Biologics reports fourth quarter and fiscal year 2025 financial results

Press Release: Biomerica Reports Second Quarter Fiscal 2026 Financial Results

Strong Earnings and Acquisition of TOT Biopharm Bolster WUXI XDC's (02268) Position in ADC CDMO Market

Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting

CLSA: WUXI APPTEC (02359) Top Pick in China's Pharma CRO/CDMO Sector, Expected to Outperform Peers This Year

Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program

Nutriband CEO Publishes Letter to Shareholders

MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan

Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference

First Case of Staggered Payment in M&A Consideration Approved by SSE's Restructuring Committee

Lepu Biopharma (SEHK:2157): Valuation Check After New GLP-1 CDMO Framework Deal With Lepu Medical

Simply Wall St.

SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery

Press Release: Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

Amaran Biotech's Vaccine Adjuvant AB-801 Receives FDA Drug Master File (DMF) Filing Acknowledgement

LEPU BIO-B (02157) Enters into CDMO Service Framework Agreement with Lepu Medical

China Securities Co., Ltd.: CXO Sector Adjustment Nears Completion, Focus on CDMO Firms with Strong Overseas Expansion and Leading Clinical CROs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CDMO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDMO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","market":"US","secType":"STK","nameCN":"Avid Bioservices, Inc.","latestPrice":12.49,"timestamp":1738702800000,"preClose":12.49,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":50623090,"shares":63963302,"eps":-2.394638,"marketStatus":"Halted","change":0,"latestTime":"02-04 16:00:00 EST","open":12.49,"high":12.49,"low":12.49,"amount":38317107.960278,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.394638,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":12.49,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDMO\",,,,,undefined,":{"symbol":"CDMO","floatShares":50623090,"roa":"-3.27%","roe":"-133.29%","lyrEps":-2.227139,"shares":63963302,"dividePrice":0,"high":12.49,"amplitude":0,"preClose":12.49,"low":12.49,"week52Low":5.9,"pbRate":"17.83","psRate":"5.31","week52High":12.51,"institutionHeld":0.9807,"latestPrice":12.49,"eps":-2.394638,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.394638,"open":12.49,"prevYearClose":12.35,"prevWeekClose":12.48,"prevMonthClose":12.48,"prevQuarterClose":12.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDMO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"CDMO","reason":null,"defaultRemindTime":1738852200000,"announcedDate":"2025-02-04","type":"delisting","dateTimestamp":1738818000000},{"market":"US","date":"2024-12-10","symbol":"CDMO","fiscalQuarterEnding":"2024/10","expectedEps":-0.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1733806800000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-09-09","symbol":"CDMO","fiscalQuarterEnding":"2024/07","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1725854400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-07-02","symbol":"CDMO","fiscalQuarterEnding":"2024/04","expectedEps":0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1719892800000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-04-24","symbol":"CDMO","fiscalQuarterEnding":"2024/01","expectedEps":-0.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"post","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDMO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDMO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1733374800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CDMO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CDMO","date":"2025-02-04","current":-5.21582,"percent":0.349064,"low":-236.80087,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"high":9284.394324,"avg":397.880667,"sd":1431.818994,"marketCap":798262008},"quantilePoints":[{"date":"2021-02-12","current":7642.459634,"twenty":-77.30512,"median":-6.716829,"eighty":-1.981915,"marketCap":1085229268},{"date":"2021-02-19","current":7616.871042,"twenty":-77.30512,"median":-6.716829,"eighty":-1.967528,"marketCap":1081595688},{"date":"2021-02-26","current":8776.887239,"twenty":-77.30512,"median":-6.716829,"eighty":-1.953306,"marketCap":1246317988},{"date":"2021-03-05","current":7574.223387,"twenty":-77.331805,"median":-6.744508,"eighty":-1.945514,"marketCap":1075539721},{"date":"2021-03-12","current":236.593569,"twenty":-77.331805,"median":-6.744508,"eighty":-1.937875,"marketCap":1053551161},{"date":"2021-03-19","current":246.292266,"twenty":-77.331805,"median":-6.744508,"eighty":-1.928906,"marketCap":1096739459},{"date":"2021-03-26","current":230.173304,"twenty":-77.278436,"median":-6.698376,"eighty":-1.924277,"marketCap":1024961724},{"date":"2021-04-01","current":262.001423,"twenty":-77.278436,"median":-6.698376,"eighty":-1.907206,"marketCap":1166692337},{"date":"2021-04-09","current":264.870052,"twenty":-77.30512,"median":-6.716829,"eighty":-1.906724,"marketCap":1179466340},{"date":"2021-04-16","current":261.72822,"twenty":-77.30512,"median":-6.716829,"eighty":-1.903436,"marketCap":1165475765},{"date":"2021-04-23","current":289.594899,"twenty":-77.30512,"median":-6.716829,"eighty":-1.897813,"marketCap":1289566086},{"date":"2021-04-30","current":292.395227,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1302035947},{"date":"2021-05-07","current":277.300776,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1234820356},{"date":"2021-05-14","current":274.432148,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888555,"marketCap":1222046353},{"date":"2021-05-21","current":274.295546,"twenty":-77.30512,"median":-6.716829,"eighty":-1.888362,"marketCap":1221438067},{"date":"2021-05-28","current":290.68771,"twenty":-77.30512,"median":-6.716829,"eighty":-1.871961,"marketCap":1294432373},{"date":"2021-06-04","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.85901,"marketCap":1407573549},{"date":"2021-06-11","current":315.68576,"twenty":-77.30512,"median":-6.716829,"eighty":-1.848648,"marketCap":1405748691},{"date":"2021-06-18","current":316.095565,"twenty":-77.30512,"median":-6.716829,"eighty":-1.841619,"marketCap":1407573549},{"date":"2021-06-25","current":342.869433,"twenty":-77.30512,"median":-6.716829,"eighty":-1.832157,"marketCap":1526797583},{"date":"2021-07-02","current":142.499473,"twenty":-77.30512,"median":-6.716829,"eighty":-1.830139,"marketCap":1597704096},{"date":"2021-07-09","current":141.845556,"twenty":-77.30512,"median":-6.716829,"eighty":-1.821934,"marketCap":1590372376},{"date":"2021-07-16","current":136.83219,"twenty":-77.30512,"median":-6.716829,"eighty":-1.81215,"marketCap":1534162518},{"date":"2021-07-23","current":141.355118,"twenty":-77.30512,"median":-6.716829,"eighty":-1.799525,"marketCap":1584873585},{"date":"2021-07-30","current":139.774818,"twenty":-77.30512,"median":-6.716829,"eighty":-1.785372,"marketCap":1567155261},{"date":"2021-08-06","current":141.73657,"twenty":-77.30512,"median":-6.716829,"eighty":-1.764864,"marketCap":1589150422},{"date":"2021-08-13","current":136.723204,"twenty":-77.30512,"median":-6.716829,"eighty":-1.688839,"marketCap":1532940565},{"date":"2021-08-20","current":135.142904,"twenty":-77.30512,"median":-6.716829,"eighty":-1.617566,"marketCap":1515222240},{"date":"2021-08-27","current":132.180722,"twenty":-77.30512,"median":-6.716829,"eighty":-1.602452,"marketCap":1482010253},{"date":"2021-09-03","current":126.490823,"twenty":-77.30512,"median":-6.716829,"eighty":-1.594862,"marketCap":1418215110},{"date":"2021-09-10","current":101.036419,"twenty":-77.30512,"median":-6.716829,"eighty":-1.573195,"marketCap":1291851653},{"date":"2021-09-17","current":100.652615,"twenty":-77.30512,"median":-6.716829,"eighty":-1.534217,"marketCap":1286944334},{"date":"2021-09-24","current":105.881945,"twenty":-77.30512,"median":-6.716829,"eighty":-1.523573,"marketCap":1353806551},{"date":"2021-10-01","current":101.180345,"twenty":-77.30512,"median":-6.716829,"eighty":-1.517157,"marketCap":1293691897},{"date":"2021-10-08","current":108.088819,"twenty":-77.30512,"median":-6.716829,"eighty":-1.495908,"marketCap":1382023634},{"date":"2021-10-15","current":123.728834,"twenty":-77.30512,"median":-6.716829,"eighty":-1.484858,"marketCap":1581996872},{"date":"2021-10-22","current":124.73632,"twenty":-77.30512,"median":-6.716829,"eighty":-1.475257,"marketCap":1594878584},{"date":"2021-10-29","current":147.188857,"twenty":-77.30512,"median":-6.716829,"eighty":-1.460883,"marketCap":1881956729},{"date":"2021-11-05","current":163.980285,"twenty":-77.30512,"median":-6.716829,"eighty":-1.456578,"marketCap":2096651923},{"date":"2021-11-12","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.445734,"marketCap":2067208010},{"date":"2021-11-19","current":161.677461,"twenty":-77.30512,"median":-6.716829,"eighty":-1.434782,"marketCap":2067208010},{"date":"2021-11-26","current":150.930947,"twenty":-77.30512,"median":-6.716829,"eighty":-1.432053,"marketCap":1929803086},{"date":"2021-12-03","current":138.697192,"twenty":-77.30512,"median":-6.716829,"eighty":92.966939,"marketCap":1773382302},{"date":"2021-12-10","current":116.804545,"twenty":-77.30512,"median":-6.716829,"eighty":99.366871,"marketCap":1638066942},{"date":"2021-12-17","current":114.169856,"twenty":-77.30512,"median":-6.716829,"eighty":101.093989,"marketCap":1601118064},{"date":"2021-12-23","current":129.714521,"twenty":-77.30512,"median":-6.716829,"eighty":102.54285,"marketCap":1819116446},{"date":"2021-12-31","current":128.133708,"twenty":-77.30512,"median":-6.716829,"eighty":106.764695,"marketCap":1796947119},{"date":"2022-01-07","current":97.527404,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1367724315},{"date":"2022-01-14","current":92.08238,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1291363300},{"date":"2022-01-21","current":79.918899,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1120782644},{"date":"2022-01-28","current":76.537715,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1073364917},{"date":"2022-02-04","current":85.056543,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192832957},{"date":"2022-02-11","current":93.180167,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1306758666},{"date":"2022-02-18","current":85.012631,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1192217143},{"date":"2022-02-25","current":88.876842,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1246408831},{"date":"2022-03-04","current":81.148421,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1138025454},{"date":"2022-03-11","current":81.564879,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1147210023},{"date":"2022-03-18","current":96.139443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1352201265},{"date":"2022-03-25","current":94.690766,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1331825629},{"date":"2022-04-01","current":94.602968,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1330590742},{"date":"2022-04-08","current":83.057455,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1168203102},{"date":"2022-04-14","current":80.379598,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1130539048},{"date":"2022-04-22","current":75.418979,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":1060767933},{"date":"2022-04-29","current":59.088443,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":831078951},{"date":"2022-05-06","current":55.444802,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":779831140},{"date":"2022-05-13","current":54.96191,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":773039262},{"date":"2022-05-20","current":55.5765,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":781683471},{"date":"2022-05-27","current":60.449321,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":850219699},{"date":"2022-06-03","current":58.868947,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":827991733},{"date":"2022-06-10","current":55.620399,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":782300914},{"date":"2022-06-17","current":58.561652,"twenty":-77.278436,"median":-6.698376,"eighty":109.201646,"marketCap":823669629},{"date":"2022-06-24","current":68.52679,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":963829303},{"date":"2022-07-01","current":7.424698,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":947926104},{"date":"2022-07-08","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-15","current":8.766278,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119208251},{"date":"2022-07-22","current":8.48537,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1083344119},{"date":"2022-07-29","current":9.516981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1215052051},{"date":"2022-08-05","current":9.376527,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1197119985},{"date":"2022-08-12","current":9.536354,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1217525439},{"date":"2022-08-19","current":8.950321,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1142705440},{"date":"2022-08-26","current":8.930948,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1140232052},{"date":"2022-09-02","current":7.824981,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":999030985},{"date":"2022-09-09","current":9.269592,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1139529431},{"date":"2022-09-16","current":8.637459,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1061820114},{"date":"2022-09-23","current":9.077423,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1115905799},{"date":"2022-09-30","current":9.669099,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1188641720},{"date":"2022-10-07","current":9.107766,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1119635846},{"date":"2022-10-14","current":8.925711,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1097255563},{"date":"2022-10-21","current":7.868786,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":967325584},{"date":"2022-10-28","current":8.971225,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1102850633},{"date":"2022-11-04","current":6.928173,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851694119},{"date":"2022-11-11","current":7.767645,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":954892093},{"date":"2022-11-18","current":7.236653,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":889616266},{"date":"2022-11-25","current":7.438936,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":914483248},{"date":"2022-12-02","current":8.298636,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":1020167920},{"date":"2022-12-09","current":6.812962,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":805660063},{"date":"2022-12-16","current":7.287183,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":861738490},{"date":"2022-12-23","current":7.202877,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":851768992},{"date":"2022-12-30","current":7.255568,"twenty":-77.30512,"median":-6.716829,"eighty":109.283255,"marketCap":857999928},{"date":"2023-01-06","current":7.740326,"twenty":-77.30512,"median":-6.679923,"eighty":109.283255,"marketCap":915324542},{"date":"2023-01-13","current":8.593922,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1016265710},{"date":"2023-01-20","current":8.66769,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1024989021},{"date":"2023-01-27","current":8.636075,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1021250459},{"date":"2023-02-03","current":8.530693,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1008788586},{"date":"2023-02-10","current":8.699305,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1028727583},{"date":"2023-02-17","current":8.720381,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1031219957},{"date":"2023-02-24","current":8.620268,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1019381178},{"date":"2023-03-03","current":9.015451,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1066113200},{"date":"2023-03-10","current":7.350412,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":869215613},{"date":"2023-03-17","current":9.559254,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1113337596},{"date":"2023-03-24","current":9.382032,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1092697068},{"date":"2023-03-31","current":10.074809,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1173382770},{"date":"2023-04-06","current":10.203698,"twenty":-77.278436,"median":-6.596886,"eighty":109.201646,"marketCap":1188394064},{"date":"2023-04-14","current":11.240179,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1309109882},{"date":"2023-04-21","current":10.289624,"twenty":-77.30512,"median":-6.606112,"eighty":109.283255,"marketCap":1198401592},{"date":"2023-04-28","current":9.50555,"twenty":-77.30512,"median":-6.513848,"eighty":109.283255,"marketCap":1107082891},{"date":"2023-05-05","current":9.919068,"twenty":-77.30512,"median":-6.458489,"eighty":109.283255,"marketCap":1155244124},{"date":"2023-05-10","current":9.731105,"twenty":-77.30512,"median":-6.403131,"eighty":109.283255,"marketCap":1133352654},{"date":"2023-05-19","current":7.835366,"twenty":-77.358489,"median":-6.20015,"eighty":109.446474,"marketCap":912561547},{"date":"2023-05-26","current":8.168329,"twenty":-77.358489,"median":-6.107885,"eighty":109.446474,"marketCap":951340721},{"date":"2023-06-02","current":8.367032,"twenty":-77.358489,"median":-6.034074,"eighty":109.446474,"marketCap":974483132},{"date":"2023-06-09","current":9.194069,"twenty":-77.358489,"median":6.812962,"eighty":109.446474,"marketCap":1070805598},{"date":"2023-06-16","current":9.118884,"twenty":-77.385174,"median":6.991758,"eighty":109.528084,"marketCap":1062049010},{"date":"2023-06-23","current":1539.104598,"twenty":-77.386973,"median":7.174145,"eighty":110.625618,"marketCap":861898575},{"date":"2023-06-30","current":1496.538387,"twenty":-77.387872,"median":7.239761,"eighty":113.886744,"marketCap":838061497},{"date":"2023-07-07","current":1540.224762,"twenty":-77.387872,"median":7.287183,"eighty":118.166944,"marketCap":862525867},{"date":"2023-07-14","current":1497.65855,"twenty":-77.387872,"median":7.366219,"eighty":123.628937,"marketCap":838688788},{"date":"2023-07-21","current":1453.972175,"twenty":-77.387872,"median":7.424698,"eighty":125.174074,"marketCap":814224418},{"date":"2023-07-28","current":1438.289888,"twenty":-77.387872,"median":7.44905,"eighty":127.470924,"marketCap":805442337},{"date":"2023-08-04","current":1365.479263,"twenty":-77.387872,"median":7.624406,"eighty":129.89895,"marketCap":764668387},{"date":"2023-08-11","current":1437.169723,"twenty":-77.387872,"median":7.767645,"eighty":131.557258,"marketCap":804815045},{"date":"2023-08-18","current":1394.603513,"twenty":-77.387872,"median":7.840439,"eighty":132.799398,"marketCap":780977967},{"date":"2023-08-25","current":1319.552561,"twenty":-77.387872,"median":7.919356,"eighty":135.055715,"marketCap":738949434},{"date":"2023-09-01","current":1329.87968,"twenty":-77.387872,"median":8.066292,"eighty":136.461637,"marketCap":744732621},{"date":"2023-09-08","current":-236.80087,"twenty":-77.627134,"median":8.093067,"eighty":136.864886,"marketCap":733372293},{"date":"2023-09-15","current":-215.810775,"twenty":-79.724891,"median":8.093067,"eighty":136.864886,"marketCap":668365971},{"date":"2023-09-22","current":-193.597957,"twenty":-81.00567,"median":8.093067,"eighty":136.864886,"marketCap":599572873},{"date":"2023-09-29","current":-198.081278,"twenty":-81.501661,"median":8.093067,"eighty":136.864886,"marketCap":613457718},{"date":"2023-10-06","current":-191.356296,"twenty":-82.284183,"median":8.093067,"eighty":136.864886,"marketCap":592630450},{"date":"2023-10-13","current":-167.309392,"twenty":-83.104206,"median":8.093067,"eighty":136.864886,"marketCap":518157188},{"date":"2023-10-20","current":-142.039764,"twenty":-83.374176,"median":8.093067,"eighty":136.864886,"marketCap":439897149},{"date":"2023-10-27","current":-132.257973,"twenty":-83.539844,"median":8.114625,"eighty":137.082858,"marketCap":409602941},{"date":"2023-11-03","current":-125.125416,"twenty":-83.933555,"median":8.114625,"eighty":137.082858,"marketCap":387513414},{"date":"2023-11-10","current":-107.599706,"twenty":-84.748881,"median":8.114625,"eighty":137.082858,"marketCap":333236291},{"date":"2023-11-17","current":-105.561833,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":326924998},{"date":"2023-11-24","current":-111.87924,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":346490007},{"date":"2023-12-01","current":-103.727747,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":321244834},{"date":"2023-12-08","current":-29.21466,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":334507860},{"date":"2023-12-15","current":-32.03385,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":366787580},{"date":"2023-12-22","current":-35.402927,"twenty":-87.127444,"median":8.103884,"eighty":136.886683,"marketCap":405363515},{"date":"2023-12-29","current":-37.501697,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":429394426},{"date":"2024-01-05","current":-33.911696,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":388288921},{"date":"2024-01-12","current":-37.336004,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":427497248},{"date":"2024-01-19","current":-33.746004,"twenty":-87.127444,"median":8.138341,"eighty":137.475209,"marketCap":386391744},{"date":"2024-01-26","current":-38.219697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":437615526},{"date":"2024-02-02","current":-36.397081,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":416746578},{"date":"2024-02-09","current":-36.562773,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":418643755},{"date":"2024-02-16","current":-42.527697,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":486942132},{"date":"2024-02-23","current":-44.12939,"twenty":-87.127444,"median":8.125366,"eighty":137.279033,"marketCap":505281511},{"date":"2024-03-01","current":-42.417236,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":485677347},{"date":"2024-03-08","current":-33.690773,"twenty":-87.127444,"median":8.114625,"eighty":137.082858,"marketCap":385759351},{"date":"2024-03-15","current":-33.635542,"twenty":-86.304259,"median":8.114625,"eighty":137.082858,"marketCap":385126959},{"date":"2024-03-22","current":-37.943543,"twenty":-85.931432,"median":8.114625,"eighty":137.082858,"marketCap":434453565},{"date":"2024-03-28","current":-38.551081,"twenty":-85.333644,"median":8.114625,"eighty":137.082858,"marketCap":441409881},{"date":"2024-04-05","current":-35.016312,"twenty":-84.693001,"median":8.125366,"eighty":137.279033,"marketCap":400936768},{"date":"2024-04-12","current":-38.109235,"twenty":-83.840428,"median":8.125366,"eighty":137.279033,"marketCap":436350742},{"date":"2024-04-19","current":-36.010466,"twenty":-83.520355,"median":8.125366,"eighty":137.279033,"marketCap":412319831},{"date":"2024-04-26","current":-26.277899,"twenty":-83.301704,"median":8.114625,"eighty":137.082858,"marketCap":464672092},{"date":"2024-05-03","current":-29.436991,"twenty":-82.558967,"median":8.114625,"eighty":137.082858,"marketCap":520534310},{"date":"2024-05-10","current":-29.221598,"twenty":-82.027926,"median":8.114625,"eighty":137.082858,"marketCap":516725523},{"date":"2024-05-17","current":-33.026868,"twenty":-81.364604,"median":8.114625,"eighty":137.082858,"marketCap":584014104},{"date":"2024-05-24","current":-31.698613,"twenty":-80.745541,"median":8.114625,"eighty":137.082858,"marketCap":560526581},{"date":"2024-05-31","current":-28.539522,"twenty":-79.544946,"median":8.114625,"eighty":137.082858,"marketCap":504664362},{"date":"2024-06-07","current":-28.826712,"twenty":-77.386073,"median":8.114625,"eighty":137.082858,"marketCap":509742745},{"date":"2024-06-14","current":-24.770151,"twenty":-75.623994,"median":8.125366,"eighty":137.279033,"marketCap":438010578},{"date":"2024-06-21","current":-24.447062,"twenty":-74.423568,"median":8.138341,"eighty":137.475209,"marketCap":432297397},{"date":"2024-06-28","current":-25.165037,"twenty":-73.302439,"median":8.168329,"eighty":137.998343,"marketCap":444993355},{"date":"2024-07-05","current":-3.47825,"twenty":-72.208373,"median":8.168329,"eighty":137.998343,"marketCap":489574115},{"date":"2024-07-12","current":-3.613766,"twenty":-71.674682,"median":8.168329,"eighty":137.998343,"marketCap":508648432},{"date":"2024-07-15","current":-3.758317,"twenty":-71.647997,"median":8.168329,"eighty":137.998343,"marketCap":528994369},{"date":"2024-08-02","current":-4.729516,"twenty":-70.687354,"median":8.235305,"eighty":139.297726,"marketCap":665693635},{"date":"2024-08-09","current":-4.774689,"twenty":-70.233717,"median":8.235305,"eighty":139.297726,"marketCap":672051740},{"date":"2024-08-16","current":-4.824378,"twenty":-69.886817,"median":8.235305,"eighty":139.297726,"marketCap":679045656},{"date":"2024-08-23","current":-4.810826,"twenty":-69.379811,"median":8.235305,"eighty":139.297726,"marketCap":677138225},{"date":"2024-08-30","current":-4.695582,"twenty":-68.84612,"median":8.235305,"eighty":139.297726,"marketCap":660917318},{"date":"2024-09-06","current":-4.079174,"twenty":-68.285745,"median":8.235305,"eighty":139.297726,"marketCap":574155972},{"date":"2024-09-13","current":-4.938462,"twenty":-67.912161,"median":8.235305,"eighty":139.297726,"marketCap":711953405},{"date":"2024-09-20","current":-5.509306,"twenty":-66.964853,"median":8.235305,"eighty":139.297726,"marketCap":794249094},{"date":"2024-09-27","current":-4.942887,"twenty":-65.87829,"median":8.235305,"eighty":139.297726,"marketCap":712591356},{"date":"2024-10-04","current":-4.672953,"twenty":-64.235019,"median":8.235305,"eighty":139.297726,"marketCap":673676340},{"date":"2024-10-11","current":-4.500373,"twenty":-63.139506,"median":8.235305,"eighty":139.297726,"marketCap":648796248},{"date":"2024-10-18","current":-4.491523,"twenty":-61.770113,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-10-25","current":-4.518073,"twenty":-60.358586,"median":8.235305,"eighty":139.297726,"marketCap":651348052},{"date":"2024-10-31","current":-4.491523,"twenty":-59.28414,"median":8.235305,"eighty":139.297726,"marketCap":647520346},{"date":"2024-11-08","current":-5.416378,"twenty":-57.72514,"median":8.243207,"eighty":139.447859,"marketCap":780852121},{"date":"2024-11-15","current":-5.292495,"twenty":-55.723721,"median":8.243207,"eighty":139.447859,"marketCap":762992503},{"date":"2024-11-22","current":-5.434456,"twenty":-53.82764,"median":8.243207,"eighty":139.447859,"marketCap":783458354},{"date":"2024-11-29","current":-5.447765,"twenty":-50.035478,"median":8.243207,"eighty":139.447859,"marketCap":785377027},{"date":"2024-12-06","current":-5.452201,"twenty":-48.666086,"median":8.243207,"eighty":139.447859,"marketCap":786016585},{"date":"2024-12-13","current":-5.178482,"twenty":-47.296694,"median":8.243207,"eighty":139.447859,"marketCap":787388247},{"date":"2024-12-20","current":-5.186896,"twenty":-46.111834,"median":8.243207,"eighty":139.447859,"marketCap":788667513},{"date":"2024-12-27","current":-5.165862,"twenty":-45.841544,"median":8.243207,"eighty":139.447859,"marketCap":785469348},{"date":"2025-01-03","current":-5.182689,"twenty":-45.510159,"median":8.243207,"eighty":139.447859,"marketCap":788027880},{"date":"2025-01-10","current":-5.207929,"twenty":-44.898573,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-17","current":-5.207929,"twenty":-44.137114,"median":8.253213,"eighty":139.458758,"marketCap":791865678},{"date":"2025-01-24","current":-5.237377,"twenty":-43.29527,"median":8.253213,"eighty":139.458758,"marketCap":796343109},{"date":"2025-01-31","current":-5.241583,"twenty":-42.152128,"median":8.253213,"eighty":139.458758,"marketCap":796982742},{"date":"2025-02-04","current":-5.249997,"twenty":-41.718676,"median":8.253213,"eighty":139.458758,"marketCap":798262008}],"updateTime":1770512476810},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDMO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608159822","title":"Bora Pharmaceuticals Unit to Buy CDMO Operational Assets for $18 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2608159822","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608159822?lang=en_us&edition=fundamental","pubTime":"2026-02-03 18:35","pubTimestamp":1770114912,"startTime":"0","endTime":"0","summary":"Bora Pharmaceuticals Co.  unit Bora Pharmaceuticals Inc. agreed to acquire contract development and manufacturing organization  operational assets in Maple Grove, Minnesota, U.S., for $18 million.The assets will be purchased from related party Upsher-Smith Laboratories, according to a Tuesday Taiwan Exchange filing.The transaction is a part of an internal operational restructuring within the group, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2607772997","title":"Press Release: Piramal Pharma Limited Announces Results for Q3 and 9M FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2607772997","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607772997?lang=en_us&edition=fundamental","pubTime":"2026-01-29 13:36","pubTimestamp":1769664960,"startTime":"0","endTime":"0","summary":"MUMBAI, India, Jan. 29, 2026 /CNW/ -- Piramal Pharma Limited  , a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Third Quarter  and Nine Month  ended 31 December 2025.Particulars                     Q3FY26  Q3FY25  YoY %   9MFY26  9MFY25  YoY %. Revenue from Operations          2,140   2,204    %   6,117   6,397    %. Nandini Piramal, Chairperson, Piramal Pharma Limited, said, \"FY26 has been a muted year for the Company due to impact of inventory destocking and slower early-stage order inflows in H1FY26 in our CDMO business. However, in recent time, we are seeing early signs of recovery with pick-up in RFPs and order inflows on the back of improved biopharma funding and increased M&A activities in the US healthcare space. In our CHG business, we are investing in new products and expanding our presence in the ex-US markets. Acquiring niche brand like Kenalog, which is synergetic to our current business, is an i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4221","TM","03160","BK4084","BK4588","CDMO","BK4555","PCH","R","BK4099","BK4604","BK4139","BK4232","BK4585","BK4022"],"gpt_icon":0},{"id":"2605910934","title":"NARMAFOTINIB Large-Scale Manufactre Complete","url":"https://stock-news.laohu8.com/highlight/detail?id=2605910934","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605910934?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:30","pubTimestamp":1769088600,"startTime":"0","endTime":"0","summary":"Successful completion of the first large-scale manufacture of narmafotinib which produced approx. 13 kg of drug Successful transition of process and production from an R&D facility to a commercial man","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/22/3223746/0/en/NARMAFOTINIB-Large-Scale-Manufactre-Complete.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","CDMO","API","BK4023","BK4551","BK4139","BK4503","INNMF"],"gpt_icon":0},{"id":"2605176614","title":"Press Release: Samsung Biologics reports fourth quarter and fiscal year 2025 financial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2605176614","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605176614?lang=en_us&edition=fundamental","pubTime":"2026-01-21 15:21","pubTimestamp":1768980060,"startTime":"0","endTime":"0","summary":"-- Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW. -- Maintained momentum through consistent operational performance and robust. INCHEON, South Korea, Jan. 20, 2026 /PRNewswire/ -- Samsung Biologics , a leading contract development and manufacturing organization , reported financial results for the fourth quarter and fiscal year 2025.Samsung Biologics continued to expand its global CDMO business through long-term partnerships with pharmaceutical companies worldwide. The company secured a KRW 1.1 trillion manufacturing agreement with a European pharmaceutical company in the fourth quarter of 2025, contributing to a cumulative contract value exceeding USD 21 b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESG","BK4604","BK4223","BK4588","CDP","TM","BK4585","BK4099","CDMO","BK4139","03160","BK4555"],"gpt_icon":0},{"id":"2603647294","title":"Press Release: Biomerica Reports Second Quarter Fiscal 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2603647294","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603647294?lang=en_us&edition=fundamental","pubTime":"2026-01-15 06:17","pubTimestamp":1768429020,"startTime":"0","endTime":"0","summary":"-- Balance Sheet Strengthens and Working Capital Improves by 14.7%. IRVINE, Calif., Jan. 14, 2026  -- Biomerica, Inc. ,  a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the second quarter of fiscal 2026 ended November 30, 2025.a marketing services agreement with Henry Schein to. IBS test in the United States. In addition, inFoods. IBS was featured in a Henry Schein publication highlighting. a precision-based approach to the management of Irritable. and support broader adoption of the test in clinical. The launch of its inFoods IBS Trigger Food Navigator,. The inFoods IBS test identifies, on average,two to four specific foods that trigger a patient's. IBS symptoms, leading to a simple, highly targeted. and actionable dietary plan. The new AI-backed Trigger. Food Navigator builds on this approach by making it. even easier for patients to follow their personalized. established a national Medicare payment rate of $300. patient ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","CMS","LU1894683264.USD","CDMO","BK4082","ERC","BK4604","LU2346227817.USD","LU1894683348.USD","BK4139","BK4099","LU0545039389.USD","LU1003077747.HKD","R","BK4555","BK4208","LU0738911758.USD","BK4588","LU2500361329.USD","LU0949170772.SGD","BMRA","BK4022","TM","BK4232","LU0661504455.SGD","BK4585","LU2637428348.USD","LU0553294199.USD"],"gpt_icon":0},{"id":"1114069729","title":"Strong Earnings and Acquisition of TOT Biopharm Bolster WUXI XDC's (02268) Position in ADC CDMO Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1114069729","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114069729?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:39","pubTimestamp":1768405156,"startTime":"0","endTime":"0","summary":"On January 14, 2026, WUXI XDC (02268) issued a positive profit alert for its 2025 fiscal year and simultaneously disclosed its launch of a voluntary conditional cash offer to acquire TOT Biopharm....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4080","BK4231","LU2488822045.USD","SG9999014674.SGD","BK1141","CDMO","ADC","02268"],"gpt_icon":0},{"id":"2603616942","title":"Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2603616942","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603616942?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:00","pubTimestamp":1768395600,"startTime":"0","endTime":"0","summary":"~ Attendees Invited to Visit Integer at Booth #115 ~PLANO, Texas, Jan.  14, 2026  (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/14/3218551/26755/en/Integer-to-Showcase-Innovations-in-Neuromodulation-Miniaturized-Active-Implantable-Device-Technology-During-NANS-2026-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1169590202.USD","LU0566484027.USD","LU0029874061.USD","LU1169589451.USD","LU1815336091.USD","BK4082","LU0757428866.USD","ITGR","LU0128526141.USD","LU1559883803.SGD","CDMO"],"gpt_icon":0},{"id":"1192674699","title":"CLSA: WUXI APPTEC (02359) Top Pick in China's Pharma CRO/CDMO Sector, Expected to Outperform Peers This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1192674699","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192674699?lang=en_us&edition=fundamental","pubTime":"2026-01-14 14:32","pubTimestamp":1768372365,"startTime":"0","endTime":"0","summary":"CLSA has released a research report stating that, looking ahead to 2026, it believes profit delivery will be more important than valuation expansion for the Chinese healthcare sector, forecasting...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603259","LU2045819591.USD","600056","BK0216","LU1808992512.USD","LU1934453819.USD","LU2125910500.SGD","02359","LU2488822045.USD","BK1583","CDMO","BK4139","LU0708995583.HKD","LU1997245177.USD","BK0188","LU1979443071.USD","BK0250","BK1141","BK0185","BK0175","LU0456842615.SGD","LU0052750758.USD","LU1997244956.HKD","BK1576","BK0082","BK0010","LU2242644610.SGD","LU2328871848.SGD","LU1046422090.SGD","LU1997245094.SGD","LU2495084118.USD","LU0320764599.SGD","BK0028","LU1969619763.USD"],"gpt_icon":0},{"id":"2603656266","title":"Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2603656266","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603656266?lang=en_us&edition=fundamental","pubTime":"2026-01-14 07:34","pubTimestamp":1768347240,"startTime":"0","endTime":"0","summary":"Signing ceremony held during the J.P. Morgan Healthcare Conference. Under the agreement, LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates, supportingRakuten Medical's global clinical development and future commercialization.Rakuten Medical's proprietary photoimmunotherapy technology is designed to selectively target cells in solid tumors, bycombining cell-targeting moieties, such as antibodies,with light-activatable agents, enabling focal and selective destruction of solid tumor cells upon light exposure.","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2861266/photo__Rakuten_Medical_and_LOTTE_Biologics_Sign_Manufacturing_Agreement_to_Support_Biopharmaceutica.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2861266/photo__Rakuten_Medical_and_LOTTE_Biologics_Sign_Manufacturing_Agreement_to_Support_Biopharmaceutica.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/rakuten-medical-and-lotte-biologics-sign-manufacturing-agreement-to-support-biopharmaceuticals-in-global-oncology-program-302660416.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CDMO"],"gpt_icon":0},{"id":"2595377939","title":"Nutriband CEO Publishes Letter to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2595377939","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595377939?lang=en_us&edition=fundamental","pubTime":"2025-12-31 20:00","pubTimestamp":1767182400,"startTime":"0","endTime":"0","summary":"ORLANDO, Fla., Dec.  31, 2025  (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on ach","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/31/3211738/0/en/Nutriband-CEO-Publishes-Letter-to-Shareholders.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","BK4099","03160","LU0267386448.USD","CMC","IE00BKVL7J92.USD","LU0882574139.USD","LU2237443978.SGD","LU2237443895.HKD","LU2746668974.SGD","BK4585","LU2746668461.USD","BK4006","CDMO","IE00BFXG1179.USD","IND","LU0170899867.USD","BK4139","NTRBW","BK4555","LU2237443622.USD","LU0149725797.USD","BK4604","BK4588","IE00BZ1G4Q59.USD","BK4007","LU0971096721.USD","LU2237443549.SGD","LU2237443382.USD","IE00BHPRN162.USD","NTRB","LU1363072403.SGD","IE00B1BXHZ80.USD","TM"],"gpt_icon":0},{"id":"2592138133","title":"MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee Osteoarthritis Treatment CARTISTEM® in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2592138133","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592138133?lang=en_us&edition=fundamental","pubTime":"2025-12-19 08:39","pubTimestamp":1766104740,"startTime":"0","endTime":"0","summary":"- South Korean biotech company secures US$8 million in upfront payment for the joint commercialization of the stem cell therapy CARTISTEM targeting the Japanese knee osteoarthritis market.SEOUL, South Korea, Dec. 19, 2025 /PRNewswire/ -- MEDIPOST Co., Ltd. , a fully integrated cell therapy biotechnology company, today announced a multi-year partnership with Japan's Teikoku Seiyaku Co., Ltd. for the commercialization of CARTISTEM, an innovative treatment for knee osteoarthritis, in the Japanese market.Antonio Seung Jin Lee, Head of MEDIPOST's Global Business Division and Co-CEO of MEDIPOST, Inc. & Akira Nakagawa, Board Member & Senior Managing Director, International Business. In turn, Teikoku Seiyaku Co. Ltd. will leverage its extensive orthopedic hospital and clinic network to promote and distribute CARTISTEM in order to accelerate CARTISTEM's adoption among patients with moderate to severe knee osteoarthritis. Teikoku Seiyaku Co. Ltd. also plans to expand its medical representative d","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2849356/image.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2849356/image.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/medipost-announces-the-exclusive-commercialization-license-agreement-with-teikoku-seiyaku-for-knee-osteoarthritis-treatment-cartistem-in-japan-302646496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139"],"gpt_icon":0},{"id":"2591981666","title":"Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2591981666","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591981666?lang=en_us&edition=fundamental","pubTime":"2025-12-16 20:00","pubTimestamp":1765886400,"startTime":"0","endTime":"0","summary":"CHASKA, Minn., Dec.  16, 2025   -- Lifecore Biomedical, Inc.  , a fully integrated contract development and manufacturing organization , today announced that the company will participate at the 44th Annual J.P. Morgan Healthcare Conference. The conference will take place January 12-15, 2026, in San Francisco, California. Details regarding Lifecore’s participation are as follows: 44th Annual J.P. Morgan Healthcare ConferenceDetails: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetings Conference Dates: January 12-15, 2026Location: San Francisco, California About Lifecore Biomedical Lifecore Biomedical, Inc.  is a fully integrated contract development and manufacturing organization  that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufac","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/16/3206095/23089/en/Lifecore-Biomedical-to-Participate-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","LU1668664300.SGD","LU1720051017.SGD","LU0106831901.USD","CFO","LU0314104364.USD","LU0128526141.USD","LU0225283273.USD","LU0029874061.USD","LU0098860793.USD","IE00BZ1G4Q59.USD","BK4504","XLV","BK4534","BK4137","LU1162221912.USD","BK4121","LU1989772840.SGD","LU1244550221.USD","LU0795875086.SGD","HCSG","LU2111349929.HKD","LU0106261372.USD","BK4585","IE00BKVL7J92.USD","XBI","LU0006306889.USD","LFCR","BK4581","LU2271345857.HKD","LU2347655156.SGD","LU1791710400.SGD","LU0795875169.SGD","LU1720051108.HKD","LU0528227936.USD","LU0557290698.USD","LU0158827781.USD","LU0912757837.SGD","LU2089284900.SGD","BK4139","LU2028103732.USD","LU1989772923.USD","LABU","LU2089283258.USD","BK4588","LU0234570918.USD","LU1732800096.USD","LU0158827948.USD","LU0971096721.USD","LU1363072403.SGD"],"gpt_icon":0},{"id":"1123969990","title":"First Case of Staggered Payment in M&A Consideration Approved by SSE's Restructuring Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1123969990","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123969990?lang=en_us&edition=fundamental","pubTime":"2025-12-10 07:12","pubTimestamp":1765321975,"startTime":"0","endTime":"0","summary":"On December 8, Shanghai OPM Biosciences Co., Ltd. (referred to as \"OPM\") received approval from the Shanghai Stock Exchange's M&A and Restructuring Committee for its share issuance to acquire assets....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139","SINA"],"gpt_icon":0},{"id":"2589822818","title":"Lepu Biopharma (SEHK:2157): Valuation Check After New GLP-1 CDMO Framework Deal With Lepu Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=2589822818","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589822818?lang=en_us&edition=fundamental","pubTime":"2025-12-05 16:31","pubTimestamp":1764923516,"startTime":"0","endTime":"0","summary":"Lepu Biopharma (SEHK:2157) just signed a GLP-1 focused CDMO framework deal with related party Lepu Medical, a move that could turn spare manufacturing capacity into recurring cashflow and reshape how investors think about its pipeline driven story.\nSee our latest analysis for Lepu Biopharma.\nThe 1 day share price return of 3.0% to HK$5.76 comes after a volatile few months, with the 3 month share price return still down sharply. However, the year to date share price return and 1 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-valuation-check-after-new-glp-1-cdmo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2157/lepu-biopharma-shares/news/lepu-biopharma-sehk2157-valuation-check-after-new-glp-1-cdmo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GLP","CDMO","BK4590","02157","BK1161","BK4144","BK4139"],"gpt_icon":0},{"id":"2588894518","title":"SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2588894518","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588894518?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:00","pubTimestamp":1764849600,"startTime":"0","endTime":"0","summary":"PRAGUE, Czech Republic and DURHAM, N.C., Dec.  04, 2025  (GLOBE NEWSWIRE) -- SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based products, and Fortrea, a leading global co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/04/3199647/0/en/SCTbio-and-Fortrea-Forge-Strategic-Collaboration-to-Accelerate-Cell-and-Gene-Therapy-Development-and-Delivery.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4139","AAQC"],"gpt_icon":0},{"id":"2588674056","title":"Press Release: Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2588674056","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588674056?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:50","pubTimestamp":1764683400,"startTime":"0","endTime":"0","summary":"JERUSALEM, Dec. 2, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd.  , a biopharmaceutical company developing innovative inflammation and immunology (I&I) therapeutics and operating a growing boutique CDMO business unit, today reported its financial results and corporate highlights for the nine months ended September 30, 2025.-- Revenues for the nine months ended September 30, 2025 were $1,049. thousand, compared to $452 thousand for the nine months ended September. 30, 2024. The increase reflects continued expansion of Scinai Bioservices,$1,799 thousand, compared to $4,195 thousand for the nine months ended. employees and facility costs to the R&D business unit.-- Marketing, general and administrative expenses for the nine months ended. September 30, 2025 were $1,929 thousand, compared to $1,767 thousand for. were $607 thousand compared to financial income of $13,374 thousand for. by the financial income from loan conversion recorded in 2024.-- Net loss for the nine months ended Se","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNI","CDMO","BK4139","BK4007"],"gpt_icon":0},{"id":"2588011053","title":"BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2588011053","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588011053?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:05","pubTimestamp":1764680700,"startTime":"0","endTime":"0","summary":"SHERIDAN, Wyo., Dec.  02, 2025  (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC” or the “Company”), an emerging provider of precision oncology diagnostics with expanding operations across Southeast","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3197900/0/en/BioNexus-Gene-Lab-Corp-Nasdaq-BGLC-Secures-500-Million-Equity-Facility-From-ARC-Group-International-to-Support-Expansion-of-Precision-Diagnostics-CDMO-Operations-and-Therapeutic-Co.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4215","BK4104","CDMO","EQR","BK4588","BK4143","BK4139","BK4585","ARC"],"gpt_icon":0},{"id":"2588208291","title":"Amaran Biotech's Vaccine Adjuvant AB-801 Receives FDA Drug Master File (DMF) Filing Acknowledgement","url":"https://stock-news.laohu8.com/highlight/detail?id=2588208291","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588208291?lang=en_us&edition=fundamental","pubTime":"2025-12-02 14:42","pubTimestamp":1764657720,"startTime":"0","endTime":"0","summary":"HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization , announced that its self-developed, GMP-grade high-purity vaccine adjuvant AB-801 has received an Acknowledgement Letter from the U.S. Food and Drug Administration  for its Type II Drug Master File . Amaran Biotech is now the first adjuvant supplier in Taiwan to obtain FDA DMF Acknowledgement. This milestone underscores the company's strong capabilities in adjuvant process development, quality management, and international regulatory compliance, while further enabling global vaccine development collaborations.Amaran Biotech has also been invited by the Hsinchu Science Park to participate in the 2025 Healthcare+ EXPO Taiwan from December 4–7, 2025. The company will exhibit at the Science Park Pavilion on the 4th floor of Hall 1 at the Taipei Nangang Exhibition Center  and warmly welcomes industry partners to visit and connect with the team.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/amaran-biotechs-vaccine-adjuvant-ab-801-receives-fda-drug-master-file-dmf-filing-acknowledgement-302630025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMF","AB","BK4590","BK4598","LU0128526141.USD","BK4139","BK4135","LU0029874061.USD","CDMO"],"gpt_icon":0},{"id":"1186478247","title":"LEPU BIO-B (02157) Enters into CDMO Service Framework Agreement with Lepu Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=1186478247","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186478247?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:50","pubTimestamp":1764319813,"startTime":"0","endTime":"0","summary":"LEPU BIO-B (02157) announced on November 28, 2025, that the company has signed a CDMO service framework agreement with Lepu Medical Technology (Beijing) Co., Ltd. Under the agreement, LEPU BIO-B...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0042","BK0028","BK0113","BK0188","BK4139","02157","BK0201","CDMO","BK0251","BK0196","300003","BK1161","BK0114"],"gpt_icon":0},{"id":"1118534015","title":"China Securities Co., Ltd.: CXO Sector Adjustment Nears Completion, Focus on CDMO Firms with Strong Overseas Expansion and Leading Clinical CROs","url":"https://stock-news.laohu8.com/highlight/detail?id=1118534015","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118534015?lang=en_us&edition=fundamental","pubTime":"2025-11-24 07:42","pubTimestamp":1763941341,"startTime":"0","endTime":"0","summary":"According to a research report by China Securities Co., Ltd., the innovative drug sector exhibits three major trends: deepening internationalization (2.0 phase), with 2025 license-out deals reaching...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601066","BK0276","CDMO","BK4139","CXO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":60,"code":"91000000","status":"200"}]}}